platelet

(redirected from Platelet preservation)
Also found in: Thesaurus, Medical, Encyclopedia.

plate·let

 (plāt′lĭt)
n.
A minute, nonnucleated, disklike cytoplasmic body found in the blood plasma of mammals that is derived from a megakaryocyte and functions to promote blood clotting. Also called blood platelet, thrombocyte.

platelet

(ˈpleɪtlɪt)
n
(Physiology) a minute cell occurring in the blood of vertebrates and involved in clotting of the blood. Formerly called: thrombocyte
[C19: a small plate]

plate•let

(ˈpleɪt lɪt)

n.
a small platelike body, esp. a blood platelet.

plate·let

(plāt′lĭt)
Any of the numerous small round structures found in the blood of mammals that function in the clotting of blood. Platelets are formed in the bone marrow, contain no nuclei, and ingest and absorb foreign particles, including viruses.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.platelet - tiny bits of protoplasm found in vertebrate bloodplatelet - tiny bits of protoplasm found in vertebrate blood; essential for blood clotting
living substance, protoplasm - the substance of a living cell (including cytoplasm and nucleus)
Translations
krevní destička

platelet

[ˈpleɪtlɪt] Nplaqueta f

platelet

[ˈpleɪtlət] (= blood cell) nplaquette fplate rack n (for drying)égouttoir m; (for storing)range-assiettes m invplate tectonics ntectonique f des plaques

platelet

n (Physiol) → Plättchen nt

platelet

[ˈpleɪtlɪt] n (Bio) → piastrina

plate·let

n. plaqueta, elemento celular esencial en la coagulación de la sangre.

platelet

n plaqueta
References in periodicals archive ?
Gish today also reported the results of a clinical study that concluded the Gish GBS polymer-based heparin bonded coating provided a better hemocompatible and biocompatible surface for cardiopulmonary bypass via protein and platelet preservation.
The company says the funding will allow researchers to complete human infusion studies with its blood platelet preservation solution and eventually with its donor organ preservation system.
Human BioSystems ("HBS" or "Company") (OTCBB:HBSC) announced today that a pre-IND (Investigational New Drug) application meeting with the FDA (Food and Drug Administration) has been scheduled for early October to discuss HBS's plan to conduct human infusion tests using the Company's patented platelet preservation system.
Slichter, an internationally recognized expert in platelet research, early findings indicate that it may be possible to augment platelet preservation from 5 days - to 8 days or more.
HyperBaric also operates its own research facility in Krasnoyarsk, Russia, which is involved in the development of its blood platelet preservation system for extending the shelf life of platelets.
The successful conclusion of these studies should allow the Company to take the next step toward FDA approval and the commercialization of the HBS platelet preservation technology," according to Dr.

Full browser ?